Presentation TCT 2014 Essentials of Mapping the Renal Nerves In Vivo Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Jie Wang September 13, 2014
Presentation TCT 2014 Essentials of Chemical Ablation Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Tim A. Fischell September 13, 2014
Presentation TCT 2014 Essentials of Ultrasound Ablation Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Joost Daemen September 13, 2014
Presentation TCT 2014 Essentials of Radiofrequency Ablation (Irrigated and Nonirrigated, Monopolar and Bipolar) Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Vivek Y. Reddy September 13, 2014
Presentation TCT 2014 Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track! Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn September 13, 2014
Presentation TCT 2014 Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Felix Mahfoud September 13, 2014
Presentation TCT 2014 TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink September 13, 2014
Presentation TCT 2014 Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Robert J. Melder September 13, 2014
Presentation TCT 2014 TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri September 13, 2014
Presentation TCT 2014 There Is Hope for Producing Preclinical Models for Successful Device Development Presenter: Gregory J. Wilson September 13, 2014
Presentation TCT 2014 Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results! Presenter: Robert S. Schwartz September 13, 2014
Presentation TCT 2014 Renal Nerve Microanatomy - The Foundation for RDN Technologies Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner September 13, 2014
Presentation TCT 2014 Affirmative: Time to Move On! Presenter: Sanjay Kaul, Ajay J. Kirtane, Sripal Bangalore September 13, 2014
Presentation TCT 2014 Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3! Presenter: Sanjay Kaul, Ajay J. Kirtane, David E. Kandzari September 13, 2014
Presentation TCT 2014 SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups Presenter: Patrick W. Serruys, Deepak L. Bhatt September 13, 2014
News Conference News ESC 2014 SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year Todd Neale September 01, 2014
News Features Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3 June 24, 2014
News Daily News Dialysis Patients with Complex Coronary Disease Fare Better at 5 Years with CABG vs PCI Caitlin E. Cox June 24, 2014
News Features Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3 June 24, 2014
News Daily News CABG Mejor que PCI en Pacientes a Diálisis con Enfermedad Coronaria Compleja Caitlin E. Cox June 24, 2014